XSHE
300435
Market cap1.17bUSD
Jul 10, Last price
20.56CNY
1D
-2.56%
1Q
-24.19%
Jan 2017
10.90%
IPO
164.38%
Name
Hangzhou Zhongtai Cryogenic Techlgy Corp
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Hangzhou Zhongtai Cryogenic Technology Corporation (HTCTC), established in 2006 and based in Hangzhou, China, is a specialist in the development, design, manufacturing, and sale of advanced cryogenic equipment. The company's extensive product range includes sophisticated packaged units such as: Cryogenic liquefaction plants for liquefied natural gas (LNG) production. Cryogenic purification plants specifically designed for liquid nitrogen washing applications. Cryogenic separation plants used in H2-CO separation processes. HTCTC also excels in producing various cold box products, catering to diverse industrial needs including LNG, liquid nitrogen washing, ethylene production, air separation units (ASU), propane dehydrogenation (PDH) propylene, methanol-to-olefins/propylene (MTO/MTP) conversions, and carbon monoxide management. Furthermore, their offerings extend to high-performance plate-fin heat exchangers, notably aluminum plate-fin heat exchangers and specialized ethylene column overhead condensers/plate-fin vessels. Serving a broad spectrum of critical industries, HTCTC's clientele spans the energy, chemical, metallurgy, electric power generation, liquefied natural gas, and modern coal chemical sectors. While primarily focused on the domestic Chinese market, the company also maintains an international presence, exporting its solutions to countries like the United States, various European nations, and India.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||